全球混合正电子发射断层扫描 (PET) 系统市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球混合正电子发射断层扫描 (PET) 系统市场 – 行业趋势和 2029 年预测

  • Medical Devices
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Hybrid Positron Emission Tomography Pet Systems Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 7.30 Billion
Diagram Market Size (Forecast Year)
USD 10.89 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Koninklijke Philips
  • CANON MEDICAL SYSTEMS
  • General Electric
  • Siemens Healthcare
  • FUJIFILM Holdings

>全球混合正电子发射断层扫描 (PET) 系统市场、应用(肿瘤学、放射学、神经病学、眼科学、心脏病学等)、最终用户(医院、诊断成像中心等)——行业趋势和预测到 2029 年。

混合正电子发射断层扫描 (PET) 系统市场

全球混合正电子发射断层扫描 (PET) 系统市场分析和规模

近年来,混合正电子发射断层扫描 (PET)系统市场预计将在预测期内快速增长。几十年来,人们一直在使用采用单一成像技术的医疗设备。虽然每种成像方法都有自己的优点,但多模态成像或多种成像技术的组合有可能提高医生的诊断准确性并有助于获得更好的治疗效果。随着全身 PET-CT 和 SPECT-CT 的出现,心血管、神经退行性疾病和癌症等关键疾病领域的解剖成像已通过结合两种成像技术的优势而占据主导地位。

  • Data Bridge Market Research 分析称,混合正电子发射断层扫描 (PET) 系统市场在 2021 年的价值为 73 亿美元,预计到 2029 年将达到 108.9 亿美元,在 2022 年至 2029 年的预测期内复合年增长率为 6.20%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

全球混合正电子发射断层扫描 (PET) 系统市场定义

将两种或多种成像技术融合成一种新形式称为混合成像。与两张照片相比,使用混合成像系统创建的图像在准确性方面更强大。除了描绘解剖结构外,混合成像还可以在体内观察更广泛的解剖材料内的分子过程。超声波、磁共振成像 (MRI)、计算机断层扫描 (CT) 和正电子发射断层扫描 (PET) 都是混合成像技术 (PET) 的形式。混合成像系统是这些技术结合的产物。

报告范围和市场细分

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制至 2019 - 2014)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

应用程序(肿瘤学、放射学、神经病学、眼科学、心脏病学等)、最终用户(医院、诊断成像中心等)

覆盖国家

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Koninklijke Philips N.V (Netherlands), CANON MEDICAL SYSTEMS CORPORATION (Japan), General Electric (US), Siemens Healthcare GmbH (Germany), FUJIFILM Holdings Corporation (Japan), Bruker (US), Hitachi Ltd. (Japan), PerkinElmer Inc. (US), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), Cubresa Inc. (Canada), Amber Diagnostics (US), Atlantis Wordwide (US), Neusoft Corporation (China), MinFound Medical Systems Co., Ltd (China), Abbott (US), Medtronic (Ireland), Agfa-Gevaert Group (Belgium), Oncovision (Valencia), CMR Naviscan (US)

Market Opportunities

  • Increase in the number of emerging markets
  • New product launch
  • Strategic collaboration of leading market players
  • Rising investment for the development of advanced technologies

Hybrid Positron Emission Tomography (PET) Systems Market Dynamics

Drivers

  • Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases such as cancer will propel the market’s growth rate during the forecast period of 2022-2029.

  • Rise in the Number of Geriatric Population

The market is being propelled forward by the growing senior population, which is prone to such disorders, as well as the growing need for convenient portable gadgets.

Furthermore, the rising importance of combination analysis of anatomic and molecular data in diagnosis of diseases will influence the growth of hybrid positron emission tomography (PET) systems market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the hybrid positron emission tomography (PET) systems market. Also, increasing expenditure on healthcare infrastructure and rising awareness about early diagnosis are the major market drivers that will further escalate the growth of hybrid Positron emission tomography (PET) systems market.

Opportunities

  • Increase in Strategic Collaborations and New product launches      

Moreover, the market's growth is fueled by an increase in the number of new product launch and strategic collaboration of leading market players. This will provide beneficial opportunities for the hybrid Positron emission tomography (PET) systems market growth.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the hybrid Positron emission tomography (PET) systems market growth during the forecast period.

Restraints/Challenges Global Hybrid Positron Emission Tomography (PET) Systems Market

On the other hand, the high cost associated with hybrid positron emission tomography (PET) systems will obstruct the growth rate of market. The dearth of skilled professionals and rising issues linked with radiation exposure will challenge the hybrid Positron emission tomography (PET) systems market. Additionally, impact of COVID-19 on supply chain and strict regulatory issues will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This hybrid positron emission tomography (PET) systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hybrid positron emission tomography (PET) systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Hybrid Positron Emission Tomography (PET) Systems Market

COVID-19 has become a huge public health issue around the world. COVID-19's spread is far from ended, and many difficulties have raised public awareness, necessitating the development of novel procedures to aid in diagnosis and treatment. The effects of COVID-19 on the brain may be precisely assessed with positron emission tomography, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting (PET). Newly diagnosed COVID-19 patients who required inpatient treatment and PET brain scans were shown to have neuronal function deficiencies, which were accompanied by cognitive impairment, and in some cases, this impairment persisted for up to six months following diagnosis. Furthermore, PET holds a lot of promise for improving and managing COVID-19. Furthermore, molecular imaging researchers would be heavily involved in the development of COVID-19-targeted medicines, helping with ex vivo screening and in vivo validation.

Recent Development

  • In June 2021, Canon Medical’s Digital PET/CT System had received the U.S. Food and Drug Administration (FDA) clearance for AI-based image reconstruction technology. The Cartesion Prime Digital PET/CT system now has 510(k) clearance for Canon Medical Systems USA Inc.'s Deep Learning Reconstruction (DLR) technology, which will be demonstrated at SNMMI 2021 for both PET and CT acquisitions. The Cartesion Prime with AiCE can assist doctors reliably and routinely produce high-quality images, paving the path for enhanced image quality, the capacity to better visualise lesions, and possibly less time spent in the scanner.

Global Hybrid Positron Emission Tomography (PET) Systems Market Scope

The hybrid positron emission tomography (PET) systems market is segmented on the basis of application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

  • Oncology
  • Radiology
  • Neurology
  • Ophthalmology
  • Cardiology
  • Others

Based on application, hybrid positron emission tomography (PET) systems market is segmented into oncology, radiology, neurology, ophthalmology, cardiology, and others.

End- User

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

Hybrid positron emission tomography (PET) systems market has also been segmented based on the end user into hospitals, diagnostic imaging centers and others.

Hybrid Positron Emission Tomography (PET) Systems Market Regional Analysis/Insights

The hybrid Positron emission tomography (PET) systems market is analysed and market size insights and trends are provided by country, application and end-user as referenced above.

The countries covered in the hybrid Positron emission tomography (PET) systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the hybrid Positron emission tomography (PET) systems market because of the well-established healthcare infrastructure and increasing awareness about advanced treatment methods in this region. Additionally, presence of major key players will flourish the market’s growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to rising use of advanced medical devices in radiology departments and development of healthcare sector this region.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

混合正电子发射断层扫描 (PET) 系统市场还为您提供详细的市场分析,包括每个国家/地区资本设备医疗保健支出的增长、混合正电子发射断层扫描 (PET) 系统市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对混合正电子发射断层扫描 (PET) 系统市场的影响。数据适用于 2010-2020 年的历史时期。

竞争格局和混合正电子发射断层扫描 (PET) 系统市场份额分析

混合正电子发射断层扫描 (PET) 系统市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对混合正电子发射断层扫描 (PET) 系统市场的关注有关。

混合正电子发射断层扫描 (PET) 系统市场的一些主要参与者包括:

  • Koninklijke Philips NV(荷兰)
  • 佳能医疗系统株式会社(日本)
  • 通用电气(美国)
  • 西门子医疗有限公司(德国)
  • 富士胶片控股株式会社(日本)
  • 布鲁克 (美国)
  • 日立有限公司(日本)
  • PerkinElmer Inc.(美国)
  • Mediso Ltd.(匈牙利)
  • MILabs BV(荷兰)
  • Cubresa Inc.(加拿大)
  • Amber Diagnostics(美国)
  • 亚特兰蒂斯全球(美国)
  • 东软集团 (中国)
  • 明方医疗系统股份有限公司 (中国)
  • 雅培(美国)
  • 美敦力(爱尔兰)
  • 爱克发吉华集团(比利时)
  • Oncovision(瓦伦西亚)
  • CMR Naviscan(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global Hybrid Positron Emission Tomography (PET) Systems Market, Application (Oncology, Radiology, Neurology, Ophthalmology, Cardiology, Others), End- User (Hospitals, Diagnostic Imaging Centers, Others) – Industry Trends and Forecast to 2029. .
The Global Hybrid Positron Emission Tomography Pet Systems Market size was valued at USD 7.30 USD Billion in 2021.
The Global Hybrid Positron Emission Tomography Pet Systems Market is projected to grow at a CAGR of 6.2% during the forecast period of 2022 to 2029.
The major players operating in the market include Koninklijke Philips, CANON MEDICAL SYSTEMS, General Electric, Siemens Healthcare, FUJIFILM Holdings, Bruker, Hitachi, PerkinElmer, Mediso, MILabs, Cubresa, Amber Diagnostics, Atlantis Wordwide, Neusoft Corporation, MinFound Medical Systems, Abbott, Medtronic, Agfa, Oncovision, CMR Naviscan.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..